pH-triggered microparticles
First Claim
1. A microparticle comprising at least one agent to be delivered, a pH triggering agent, and a polymer, wherein the polymer is selected from the group of polymethacrylates and polyacrylates.
5 Assignments
0 Petitions
Accused Products
Abstract
Microparticles that are designed to release their payload when exposed to acidic conditions are provided as a vehicle for drug delivery. Any therapeutic, diagnostic, or prophylatic agent may be encapsulated in a lipid-protein-sugar or polymeric matrix including a pH triggering agent to form pH triggerable microparticles. Preferably the diameter of the pH triggered microparticles ranges from 50 nm to 10 micrometers. The matrix of the particles may be prepared using any known lipid (e.g., DPPC), protein (e.g., albumin), or sugar (e.g., lactose). The matrix of the particles may also be prepared using any synthetic polymers such as polyesters. Methods of preparing and administering the particles are provided. Methods of immunization, transfection, and gene therapy are also provided by administering pH triggerable microparticles.
118 Citations
72 Claims
- 1. A microparticle comprising at least one agent to be delivered, a pH triggering agent, and a polymer, wherein the polymer is selected from the group of polymethacrylates and polyacrylates.
- 2. A microparticle comprising at least one agent to be delivered, a pH triggering agent, and at least two components selected from the group consisting of lipids, proteins, sugars, and polymers.
- 31. A pharmaceutical composition comprising pH triggered microparticles, wherein the microparticles comprise at least one agent to be delivered, a polymer, and a pH triggering agent.
- 32. A pharmaceutical composition comprising pH-triggered microparticles of at least one agent encapsulated in a matrix comprising a lipid, a protein, and a pH triggering agent.
-
56. A method of administering a pH-triggered microparticles, the method comprising steps of:
-
providing a patient;
providing a pharmaceutical composition comprising pH-triggered microparticles comprising at least one agent, a protein, a lipid, and a pH triggering agent;
administering the pharmaceutical composition to the patient. - View Dependent Claims (57, 58, 59, 60, 61, 62, 63)
-
-
64. A method of transfection, the method comprising steps of:
-
providing at least one cell;
providing a composition comprising pH-triggered microparticles comprising a polynucleotide, a protein, a lipid, and a pH triggering agent;
contacting the cell with the composition to achieve transfection of the polynucleotide into the cell.
-
-
65. A method of immunizing a patient, the method comprising steps of:
-
providing a patient to be immunized;
providing a pharmaceutical composition comprising an antigen encapsulated in a matrix of lipid, protein, and pH triggering agent;
administering an effective amount of the pharmaceutical composition to the patient to stimulate an immune response. - View Dependent Claims (66, 67)
-
-
68. A method of treating a patient in need of gene therapy, the method comprising steps of:
-
providing a patient to be treated;
providing a pharmaceutical composition comprising a polynucleotide encapsulated in a matrix of lipid, protein, and pH triggering agent;
administering an effective amount of the pharmaceutical composition to the patient to result in transfection of at least one cell of the patient.
-
-
69. A method of preparing pH-triggered microparticles, the method comprising steps of:
-
providing an agent;
contacting the agent with a pH triggering agent and at least one component selected from the group consisting of lipids, proteins, sugars, and polymers; and
spray-drying resulting mixture to create microparticles. - View Dependent Claims (70, 71, 72)
-
Specification